New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

Today's Free Fly Stories
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 >>
06:08 EDTMTArcelorMittal downgraded to Neutral from Overweight at JPMorgan
Subscribe for More Information
06:08 EDTITCITC Holdings to be acquired by Fortis for in deal valued at $11.3B
Subscribe for More Information
06:08 EDTCONNConn's reports Q4 revenue $376.5M, consensus $455.88M
Conn's reported $101.0M in total retail net sales for the month ended January 31 a 7.9% increase compared to the same prior year period. For the three months ended January 31 total retail net sales were $376.5M, a 7.4% increase compared to the same prior year period. Company said, "Greater than 60-day delinquency was 9.9% as of January 31 compared to 9.7% as of January 31, 2015. The delinquency rate was flat as of January 31 compared to December 31, 2015, consistent with the trend in the same period a year ago."
06:08 EDTSAVESpirit Airlines reports Q4 total revenue per passenger flight segment down 12.6%
Subscribe for More Information
06:07 EDTGWRGenesee & Wyoming reports Q4 N American traffic down 14.8% to 388,228 carloads
Australian Operations traffic decreased 8,111 carloads, or 14.9%, to 46,245 carloads in the fourth quarter of 2015. Operating revenues from G&W's U.K./European Operations increased $156.1 million to $161.0 million in the fourth quarter of 2015, compared with $5.0 million in the fourth quarter of 2014 as a result of the newly acquired Freightliner U.K./European operations.
06:06 EDTGWRGenesee & Wyoming raises FY16 free cash flow by 10% to $285M
Subscribe for More Information
06:06 EDTRTRXGoldman Sachs reports 5.4% passive stake in Retrophin
The Goldman Sachs Group reported a 5.4% stake in biopharmaceutical company Retrophin. Goldman owns over 1.94M shares of the company focused on diseases affecting children, including focal segmental glomerulosclerosis and pantothenate kinase-associated neurodegeneration. Retrophin closed yesterday down 77c to $14.16.
06:05 EDTGWRGenesee & Wyoming to concentrate on commercial development worldwide
Cuts investment in plant and equipment to be consistent with lower traffic levels. The company announced it has made expense reductions in every operating region, with Australia now initiating a second round of cost cuts and the U.K./Europe planning significant cost reductions and a restructuring of UK coal business in 1H16.
06:04 EDTNCMGYNewcrest Mining says Indonesian gold mine halted, one employee trapped
Subscribe for More Information
06:04 EDTGWRGenesee & Wyoming: 2015 trends show few signs of abating in 2016
The company commented, "The trends that made 2015 difficult show few signs of abating in 2016. In North America, we anticipate our operating income to be down slightly as sustained weakness in coal and steel shipments is expected to offset positive trends such as core pricing. In Australia, we expect a decline in operating income due to the recent closure of a manganese mine and continued pressure on our remaining iron ore business. In the U.K./Europe, we expect operating income to be flat, but to improve in the second half of 2016 after we complete the restructuring of the U.K. coal business. The net impact of these trends and weaker foreign currencies is that we expect our adjusted diluted EPS to be down approximately 10% in 2016."
06:04 EDTITCITC Holdings to be acquired by Fortis for $11.3B
Subscribe for More Information
06:03 EDTGWRGenesee & Wyoming: All 3 operating segments continue to face weak shipments
Subscribe for More Information
06:03 EDTSTESTERIS reports Q3 EPS 98c, consensus 94c
Reports Q3 revenue $618.7M, consensus $617.79M.
06:02 EDTAINVApollo Investment reports Q3 EPS 21c, consensus 21c
Subscribe for More Information
06:02 EDTSAVESpirit Airlines reports Q4 adjusted EPS $1.02, consensus 99c
Subscribe for More Information
06:02 EDTQLYSQualys price target lowered to $32 from $37 at JPMorgan
JPMorgan analyst Sterling Auty cut his price target for Qualys to $32 saying the company's "challenging" 2015 closed yesterday with a revenue miss in Q4 and a slower outlook for 2016. He keeps an Underweight rating on the shares.
06:01 EDTGWRGenesee & Wyoming reports Q4 adjusted EPS 85c, consensus 86c
Subscribe for More Information
06:01 EDTNFIB Small Business Optimism Index level data reported
January NFIB Small Business Optimism Index level at 93.9 vs. consensus of 94.9
06:00 EDTKKRKKR to acquire 50% stake in Swedish industrial R&D company Valinge
Subscribe for More Information
06:00 EDTQDELQuidel downgraded to Hold from Buy at Canaccord
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use